ltrasound-guided breast-sparing surgery to improve cosmetic outcomes and quality of life.
- Conditions
- Invasive mammacarcinoma / malignant breast tumour10006295
- Registration Number
- NL-OMON36758
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
Women age 25-75 yrs who are diagnosed with palpable early-stage (T1-2N0-1) primary breast cancer in the trial centres.
Breast cancer will be diagnosed with physical examination, mammography (2R) and US of the breast and axilla. The diagnosis of invasive (ductal or lobular) breast cancer will be established with image-guided core needle biopsy or cytological puncture.
All patients will be suitable for BCT according to national guidelines.
Participants will not have a history of prior mammary surgery in the affected breast, radiation therapy or neo-adjuvant therapy.
Participants will have ASA Classification I - III and will be well-informed having signed an informed consent form.
Participants with a history of prior mamma surgery, radiation therapy or neo-adjuvant therapy.
Patients younger than 25 years, patients age above 75 years.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method